Global Gene Delivery System Technology Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 109
Published Date: 09 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Gene Delivery System Technology Drug market size was valued at USD 9325.4 million in 2023 and is forecast to a readjusted size of USD 32040 million by 2030 with a CAGR of 19.3% during review period.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
The Global Info Research report includes an overview of the development of the Gene Delivery System Technology Drug industry chain, the market status of Neurological Diseases (Viral Gene Delivery System, Non-viral Gene Delivery System), Cancer (Viral Gene Delivery System, Non-viral Gene Delivery System), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Delivery System Technology Drug.
Regionally, the report analyzes the Gene Delivery System Technology Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Delivery System Technology Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene Delivery System Technology Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Delivery System Technology Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Viral Gene Delivery System, Non-viral Gene Delivery System).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Delivery System Technology Drug market.
Regional Analysis: The report involves examining the Gene Delivery System Technology Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Delivery System Technology Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene Delivery System Technology Drug:
Company Analysis: Report covers individual Gene Delivery System Technology Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Delivery System Technology Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Neurological Diseases, Cancer).
Technology Analysis: Report covers specific technologies relevant to Gene Delivery System Technology Drug. It assesses the current state, advancements, and potential future developments in Gene Delivery System Technology Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Delivery System Technology Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene Delivery System Technology Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Market segment by Application
Neurological Diseases
Cancer
Other
Market segment by players, this report covers
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Delivery System Technology Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Delivery System Technology Drug, with revenue, gross margin and global market share of Gene Delivery System Technology Drug from 2019 to 2024.
Chapter 3, the Gene Delivery System Technology Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Delivery System Technology Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Delivery System Technology Drug.
Chapter 13, to describe Gene Delivery System Technology Drug research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gene Delivery System Technology Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Delivery System Technology Drug by Type
1.3.1 Overview: Global Gene Delivery System Technology Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Gene Delivery System Technology Drug Consumption Value Market Share by Type in 2023
1.3.3 Viral Gene Delivery System
1.3.4 Non-viral Gene Delivery System
1.4 Global Gene Delivery System Technology Drug Market by Application
1.4.1 Overview: Global Gene Delivery System Technology Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Neurological Diseases
1.4.3 Cancer
1.4.4 Other
1.5 Global Gene Delivery System Technology Drug Market Size & Forecast
1.6 Global Gene Delivery System Technology Drug Market Size and Forecast by Region
1.6.1 Global Gene Delivery System Technology Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Gene Delivery System Technology Drug Market Size by Region, (2019-2030)
1.6.3 North America Gene Delivery System Technology Drug Market Size and Prospect (2019-2030)
1.6.4 Europe Gene Delivery System Technology Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Gene Delivery System Technology Drug Market Size and Prospect (2019-2030)
1.6.6 South America Gene Delivery System Technology Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Gene Delivery System Technology Drug Market Size and Prospect (2019-2030)
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Gene Delivery System Technology Drug Product and Solutions
2.1.4 Biogen Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Biogen Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Gene Delivery System Technology Drug Product and Solutions
2.2.4 Novartis Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Gene Delivery System Technology Drug Product and Solutions
2.3.4 Gilead Sciences Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics Gene Delivery System Technology Drug Product and Solutions
2.4.4 Sarepta Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
2.5 Alnylam Pharmaceuticals
2.5.1 Alnylam Pharmaceuticals Details
2.5.2 Alnylam Pharmaceuticals Major Business
2.5.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product and Solutions
2.5.4 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Gene Delivery System Technology Drug Product and Solutions
2.6.4 Amgen Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Spark Therapeutics
2.7.1 Spark Therapeutics Details
2.7.2 Spark Therapeutics Major Business
2.7.3 Spark Therapeutics Gene Delivery System Technology Drug Product and Solutions
2.7.4 Spark Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Spark Therapeutics Recent Developments and Future Plans
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Gene Delivery System Technology Drug Product and Solutions
2.8.4 Akcea Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Akcea Therapeutics Recent Developments and Future Plans
2.9 bluebird bio
2.9.1 bluebird bio Details
2.9.2 bluebird bio Major Business
2.9.3 bluebird bio Gene Delivery System Technology Drug Product and Solutions
2.9.4 bluebird bio Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 bluebird bio Recent Developments and Future Plans
2.10 Sunway Biotech
2.10.1 Sunway Biotech Details
2.10.2 Sunway Biotech Major Business
2.10.3 Sunway Biotech Gene Delivery System Technology Drug Product and Solutions
2.10.4 Sunway Biotech Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sunway Biotech Recent Developments and Future Plans
2.11 SIBIONO
2.11.1 SIBIONO Details
2.11.2 SIBIONO Major Business
2.11.3 SIBIONO Gene Delivery System Technology Drug Product and Solutions
2.11.4 SIBIONO Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 SIBIONO Recent Developments and Future Plans
2.12 AnGes
2.12.1 AnGes Details
2.12.2 AnGes Major Business
2.12.3 AnGes Gene Delivery System Technology Drug Product and Solutions
2.12.4 AnGes Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 AnGes Recent Developments and Future Plans
2.13 Orchard Therapeutics
2.13.1 Orchard Therapeutics Details
2.13.2 Orchard Therapeutics Major Business
2.13.3 Orchard Therapeutics Gene Delivery System Technology Drug Product and Solutions
2.13.4 Orchard Therapeutics Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Orchard Therapeutics Recent Developments and Future Plans
2.14 Human Stem Cells Institute
2.14.1 Human Stem Cells Institute Details
2.14.2 Human Stem Cells Institute Major Business
2.14.3 Human Stem Cells Institute Gene Delivery System Technology Drug Product and Solutions
2.14.4 Human Stem Cells Institute Gene Delivery System Technology Drug Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Human Stem Cells Institute Recent Developments and Future Plans
3.1 Global Gene Delivery System Technology Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Gene Delivery System Technology Drug by Company Revenue
3.2.2 Top 3 Gene Delivery System Technology Drug Players Market Share in 2023
3.2.3 Top 6 Gene Delivery System Technology Drug Players Market Share in 2023
3.3 Gene Delivery System Technology Drug Market: Overall Company Footprint Analysis
3.3.1 Gene Delivery System Technology Drug Market: Region Footprint
3.3.2 Gene Delivery System Technology Drug Market: Company Product Type Footprint
3.3.3 Gene Delivery System Technology Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Gene Delivery System Technology Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global Gene Delivery System Technology Drug Market Forecast by Type (2025-2030)
5.1 Global Gene Delivery System Technology Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global Gene Delivery System Technology Drug Market Forecast by Application (2025-2030)
6.1 North America Gene Delivery System Technology Drug Consumption Value by Type (2019-2030)
6.2 North America Gene Delivery System Technology Drug Consumption Value by Application (2019-2030)
6.3 North America Gene Delivery System Technology Drug Market Size by Country
6.3.1 North America Gene Delivery System Technology Drug Consumption Value by Country (2019-2030)
6.3.2 United States Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
6.3.3 Canada Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
7.1 Europe Gene Delivery System Technology Drug Consumption Value by Type (2019-2030)
7.2 Europe Gene Delivery System Technology Drug Consumption Value by Application (2019-2030)
7.3 Europe Gene Delivery System Technology Drug Market Size by Country
7.3.1 Europe Gene Delivery System Technology Drug Consumption Value by Country (2019-2030)
7.3.2 Germany Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
7.3.3 France Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
7.3.5 Russia Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
7.3.6 Italy Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region
8.3.1 Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Region (2019-2030)
8.3.2 China Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
8.3.3 Japan Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
8.3.5 India Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
8.3.7 Australia Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
9.1 South America Gene Delivery System Technology Drug Consumption Value by Type (2019-2030)
9.2 South America Gene Delivery System Technology Drug Consumption Value by Application (2019-2030)
9.3 South America Gene Delivery System Technology Drug Market Size by Country
9.3.1 South America Gene Delivery System Technology Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country
10.3.1 Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
10.3.4 UAE Gene Delivery System Technology Drug Market Size and Forecast (2019-2030)
11.1 Gene Delivery System Technology Drug Market Drivers
11.2 Gene Delivery System Technology Drug Market Restraints
11.3 Gene Delivery System Technology Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Gene Delivery System Technology Drug Industry Chain
12.2 Gene Delivery System Technology Drug Upstream Analysis
12.3 Gene Delivery System Technology Drug Midstream Analysis
12.4 Gene Delivery System Technology Drug Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Gene Delivery System Technology Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gene Delivery System Technology Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Gene Delivery System Technology Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Gene Delivery System Technology Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Biogen Company Information, Head Office, and Major Competitors
Table 6. Biogen Major Business
Table 7. Biogen Gene Delivery System Technology Drug Product and Solutions
Table 8. Biogen Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Biogen Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Gene Delivery System Technology Drug Product and Solutions
Table 13. Novartis Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 16. Gilead Sciences Major Business
Table 17. Gilead Sciences Gene Delivery System Technology Drug Product and Solutions
Table 18. Gilead Sciences Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Gilead Sciences Recent Developments and Future Plans
Table 20. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Sarepta Therapeutics Major Business
Table 22. Sarepta Therapeutics Gene Delivery System Technology Drug Product and Solutions
Table 23. Sarepta Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Sarepta Therapeutics Recent Developments and Future Plans
Table 25. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Alnylam Pharmaceuticals Major Business
Table 27. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product and Solutions
Table 28. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 30. Amgen Company Information, Head Office, and Major Competitors
Table 31. Amgen Major Business
Table 32. Amgen Gene Delivery System Technology Drug Product and Solutions
Table 33. Amgen Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Amgen Recent Developments and Future Plans
Table 35. Spark Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Spark Therapeutics Major Business
Table 37. Spark Therapeutics Gene Delivery System Technology Drug Product and Solutions
Table 38. Spark Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Spark Therapeutics Recent Developments and Future Plans
Table 40. Akcea Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Akcea Therapeutics Major Business
Table 42. Akcea Therapeutics Gene Delivery System Technology Drug Product and Solutions
Table 43. Akcea Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Akcea Therapeutics Recent Developments and Future Plans
Table 45. bluebird bio Company Information, Head Office, and Major Competitors
Table 46. bluebird bio Major Business
Table 47. bluebird bio Gene Delivery System Technology Drug Product and Solutions
Table 48. bluebird bio Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. bluebird bio Recent Developments and Future Plans
Table 50. Sunway Biotech Company Information, Head Office, and Major Competitors
Table 51. Sunway Biotech Major Business
Table 52. Sunway Biotech Gene Delivery System Technology Drug Product and Solutions
Table 53. Sunway Biotech Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sunway Biotech Recent Developments and Future Plans
Table 55. SIBIONO Company Information, Head Office, and Major Competitors
Table 56. SIBIONO Major Business
Table 57. SIBIONO Gene Delivery System Technology Drug Product and Solutions
Table 58. SIBIONO Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. SIBIONO Recent Developments and Future Plans
Table 60. AnGes Company Information, Head Office, and Major Competitors
Table 61. AnGes Major Business
Table 62. AnGes Gene Delivery System Technology Drug Product and Solutions
Table 63. AnGes Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. AnGes Recent Developments and Future Plans
Table 65. Orchard Therapeutics Company Information, Head Office, and Major Competitors
Table 66. Orchard Therapeutics Major Business
Table 67. Orchard Therapeutics Gene Delivery System Technology Drug Product and Solutions
Table 68. Orchard Therapeutics Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Orchard Therapeutics Recent Developments and Future Plans
Table 70. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
Table 71. Human Stem Cells Institute Major Business
Table 72. Human Stem Cells Institute Gene Delivery System Technology Drug Product and Solutions
Table 73. Human Stem Cells Institute Gene Delivery System Technology Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Human Stem Cells Institute Recent Developments and Future Plans
Table 75. Global Gene Delivery System Technology Drug Revenue (USD Million) by Players (2019-2024)
Table 76. Global Gene Delivery System Technology Drug Revenue Share by Players (2019-2024)
Table 77. Breakdown of Gene Delivery System Technology Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Gene Delivery System Technology Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Gene Delivery System Technology Drug Players
Table 80. Gene Delivery System Technology Drug Market: Company Product Type Footprint
Table 81. Gene Delivery System Technology Drug Market: Company Product Application Footprint
Table 82. Gene Delivery System Technology Drug New Market Entrants and Barriers to Market Entry
Table 83. Gene Delivery System Technology Drug Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Gene Delivery System Technology Drug Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Gene Delivery System Technology Drug Consumption Value Share by Type (2019-2024)
Table 86. Global Gene Delivery System Technology Drug Consumption Value Forecast by Type (2025-2030)
Table 87. Global Gene Delivery System Technology Drug Consumption Value by Application (2019-2024)
Table 88. Global Gene Delivery System Technology Drug Consumption Value Forecast by Application (2025-2030)
Table 89. North America Gene Delivery System Technology Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Gene Delivery System Technology Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Gene Delivery System Technology Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Gene Delivery System Technology Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Gene Delivery System Technology Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Gene Delivery System Technology Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Gene Delivery System Technology Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Gene Delivery System Technology Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Gene Delivery System Technology Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Gene Delivery System Technology Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Gene Delivery System Technology Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Gene Delivery System Technology Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Gene Delivery System Technology Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Gene Delivery System Technology Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Gene Delivery System Technology Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Gene Delivery System Technology Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Gene Delivery System Technology Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Gene Delivery System Technology Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Gene Delivery System Technology Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Gene Delivery System Technology Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Gene Delivery System Technology Drug Raw Material
Table 120. Key Suppliers of Gene Delivery System Technology Drug Raw Materials
List of Figures
Figure 1. Gene Delivery System Technology Drug Picture
Figure 2. Global Gene Delivery System Technology Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gene Delivery System Technology Drug Consumption Value Market Share by Type in 2023
Figure 4. Viral Gene Delivery System
Figure 5. Non-viral Gene Delivery System
Figure 6. Global Gene Delivery System Technology Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Gene Delivery System Technology Drug Consumption Value Market Share by Application in 2023
Figure 8. Neurological Diseases Picture
Figure 9. Cancer Picture
Figure 10. Other Picture
Figure 11. Global Gene Delivery System Technology Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Gene Delivery System Technology Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Gene Delivery System Technology Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Gene Delivery System Technology Drug Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Gene Delivery System Technology Drug Consumption Value Market Share by Region in 2023
Figure 16. North America Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Gene Delivery System Technology Drug Revenue Share by Players in 2023
Figure 22. Gene Delivery System Technology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Gene Delivery System Technology Drug Market Share in 2023
Figure 24. Global Top 6 Players Gene Delivery System Technology Drug Market Share in 2023
Figure 25. Global Gene Delivery System Technology Drug Consumption Value Share by Type (2019-2024)
Figure 26. Global Gene Delivery System Technology Drug Market Share Forecast by Type (2025-2030)
Figure 27. Global Gene Delivery System Technology Drug Consumption Value Share by Application (2019-2024)
Figure 28. Global Gene Delivery System Technology Drug Market Share Forecast by Application (2025-2030)
Figure 29. North America Gene Delivery System Technology Drug Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Gene Delivery System Technology Drug Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Gene Delivery System Technology Drug Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Gene Delivery System Technology Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Gene Delivery System Technology Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Gene Delivery System Technology Drug Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 39. France Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Gene Delivery System Technology Drug Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Gene Delivery System Technology Drug Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Gene Delivery System Technology Drug Consumption Value Market Share by Region (2019-2030)
Figure 46. China Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 49. India Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Gene Delivery System Technology Drug Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Gene Delivery System Technology Drug Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Gene Delivery System Technology Drug Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Gene Delivery System Technology Drug Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Gene Delivery System Technology Drug Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Gene Delivery System Technology Drug Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Gene Delivery System Technology Drug Consumption Value (2019-2030) & (USD Million)
Figure 63. Gene Delivery System Technology Drug Market Drivers
Figure 64. Gene Delivery System Technology Drug Market Restraints
Figure 65. Gene Delivery System Technology Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Gene Delivery System Technology Drug in 2023
Figure 68. Manufacturing Process Analysis of Gene Delivery System Technology Drug
Figure 69. Gene Delivery System Technology Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Biogen Novartis Gilead Sciences Sarepta Therapeutics Alnylam Pharmaceuticals Amgen Spark Therapeutics Akcea Therapeutics bluebird bio Sunway Biotech SIBIONO AnGes Orchard Therapeutics Human Stem Cells Institute
Related Reports
09 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
